Indaptus Therapeutics Secures $12M in Deeply Discounted Offshore Private Placement at $0.60/Share
INDP has more than doubled off its 52-week low of $0.92 on light trading volume (0.1× avg).
Summary
Indaptus Therapeutics raised $12 million through an offshore private placement, selling 20 million common shares at $0.60 per share. This financing follows the company's Q1 report revealing a critically low cash balance of $1.5 million and a $7.0 million quarterly burn rate, and an 8-K filing on the same day disclosing this raise. The $12 million provides a crucial, albeit temporary, cash infusion for the financially distressed company, potentially covering more than a quarter of its operating expenses. However, the shares were sold at a significant discount to the current market price of $3.55, indicating substantial dilution for existing shareholders. The company is also seeking shareholder approval for a much larger $300 million capital raise, which would be even more dilutive.
At the time of this announcement, INDP was trading at $3.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $402M. The 52-week trading range was $0.92 to $14.84. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.